OptiNose (OPTN) News Today → Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad) Free OPTN Stock Alerts $1.01 +0.13 (+14.77%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRecent uptick might appease OptiNose, Inc. (NASDAQ:OPTN) institutional owners after losing 50% over the past yearfinance.yahoo.com - May 5 at 7:14 PMHC Wainwright Comments on OptiNose, Inc.'s Q1 2024 Earnings (NASDAQ:OPTN)americanbankingnews.com - May 2 at 1:24 AMQ1 2024 EPS Estimates for OptiNose, Inc. Increased by Analyst (NASDAQ:OPTN)marketbeat.com - May 1 at 7:51 AMHC Wainwright Reiterates "Buy" Rating for OptiNose (NASDAQ:OPTN)americanbankingnews.com - May 1 at 7:06 AMAfter key Xhance approval, Optinose outlines plan to quadruple sales and reach profitabilitybizjournals.com - April 29 at 2:38 PMOptiNose's (OPTN) "Buy" Rating Reiterated at HC Wainwrightmarketbeat.com - April 29 at 8:06 AMOptiNose, Inc. (OPTN)finance.yahoo.com - April 27 at 2:05 PMWhy Is OptiNose (OPTN) Stock Up 12% Today?investorplace.com - April 25 at 10:51 AMOptinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 millionglobenewswire.com - April 25 at 7:00 AMOptinose to Present at Needham Virtual Healthcare Conferencemsn.com - April 7 at 9:30 AMOptiNose (NASDAQ:OPTN) shareholders have endured a 87% loss from investing in the stock five years agofinance.yahoo.com - April 6 at 2:26 PMOptinose to Present at the Needham Virtual Healthcare Conferenceglobenewswire.com - April 4 at 4:01 PMMichael F. Marino III Sells 15,059 Shares of OptiNose, Inc. (NASDAQ:OPTN) Stockinsidertrades.com - March 20 at 7:32 AMInsider Selling: OptiNose, Inc. (NASDAQ:OPTN) Insider Sells 15,059 Shares of Stockmarketbeat.com - March 19 at 1:24 PMOptiNose (NASDAQ:OPTN) Price Target Raised to $4.00marketbeat.com - March 18 at 2:53 PMOptinose, Inc.: XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polypsfinanznachrichten.de - March 16 at 1:18 PMOptiNose granted FDA nod to expand labeling for sinusitis therapymsn.com - March 16 at 1:18 PMBucks County's Optinose wins FDA approval for wider use of flagship productbizjournals.com - March 15 at 8:58 PMXHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polypsglobenewswire.com - March 15 at 3:34 PMmarketbeat.com - March 15 at 3:33 PMOptinose primed for FDA ruling on Xhance that could 'reshape' its futurebizjournals.com - March 13 at 8:17 PMOptiNose (NASDAQ:OPTN) Coverage Initiated by Analysts at HC Wainwrightmarketbeat.com - March 11 at 8:16 AMUS$3.00: That's What Analysts Think OptiNose, Inc. (NASDAQ:OPTN) Is Worth After Its Latest Resultsfinance.yahoo.com - March 10 at 1:35 PMOptiNose, Inc. (OPTN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 10 at 12:26 AMOptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 8 at 12:56 PMOptiNose (NASDAQ:OPTN) Announces Quarterly Earnings Resultsmarketbeat.com - March 8 at 11:54 AMOptiNose Full Year 2023 Earnings: EPS Beats Expectationsfinance.yahoo.com - March 8 at 7:55 AMOptiNose Inc (OPTN) Reports Decline in 2023 Revenue Amidst Preparations for Potential XHANCE ...finance.yahoo.com - March 7 at 4:14 PMOPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023investorplace.com - March 7 at 2:01 PMOptinose, Inc.: Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlightsfinanznachrichten.de - March 7 at 10:19 AMOptinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlightsfinance.yahoo.com - March 7 at 10:19 AMOptiNose reports mixed results; initiates Q1 and FY24 outlookmsn.com - March 7 at 10:19 AMOptiNose: Q4 Earnings Snapshotwashingtonpost.com - March 7 at 10:19 AMOptinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlightsglobenewswire.com - March 7 at 7:00 AMOptiNose's Earnings: A Previewbenzinga.com - March 6 at 6:45 PMOptiNose (OPTN) Scheduled to Post Earnings on Thursdaymarketbeat.com - March 1 at 2:55 PMOptinose Announces Reporting Date for Fourth Quarter 2023 Financial Resultsglobenewswire.com - February 29 at 4:40 PM3 Pharma Stocks to Consider for March Gainsentrepreneur.com - February 29 at 8:06 AMOptinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practicefinance.yahoo.com - January 18 at 1:57 PMRamy A. Mahmoud Sells 11,114 Shares of OptiNose, Inc. (NASDAQ:OPTN) Stockmarketbeat.com - December 20 at 3:25 PMWhy ENT-Focused OptiNose Shares Are Diving Todaymsn.com - December 6 at 12:00 PMOptinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCEfinance.yahoo.com - December 6 at 12:00 PMOptinose to Present at the 35th Annual Piper Sandler Healthcare Conferencefinance.yahoo.com - November 22 at 10:28 AMOptiNose Inc OPTNmorningstar.com - November 18 at 11:26 PMOwning 47% shares,institutional owners seem interested in OptiNose, Inc. (NASDAQ:OPTN),finance.yahoo.com - November 17 at 9:47 AMOptiNose, Inc. (NASDAQ:OPTN) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 11 at 2:40 PMPiper Sandler Reaffirms Their Buy Rating on Optinose (OPTN)markets.businessinsider.com - November 11 at 9:40 AMOptinose Reports Third Quarter 2023 Financial Results and Operational Updatesfinance.yahoo.com - November 9 at 9:29 AMOptinose Reports Third Quarter 2023 Financial Results and Operational Updatesfinance.yahoo.com - November 9 at 9:29 AMOptiNose Inc (OPTN) Reports Q3 2023 Financial Results with Improved Operating Efficiencyfinance.yahoo.com - November 9 at 9:29 AM Get OptiNose News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTN and its competitors with MarketBeat's FREE daily newsletter. Email Address The Next Nvidia? (Ad)The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about. Go here now for this breaking story. OPTN Media Mentions By Week OPTN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPTN News Sentiment▼0.570.42▲Average Medical News Sentiment OPTN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPTN Articles This Week▼101▲OPTN Articles Average Week Get OptiNose News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cartesian Therapeutics News Immunic News FibroGen News CytomX Therapeutics News Eliem Therapeutics News Seres Therapeutics News Rezolute News Clearside Biomedical News Societal CDMO News Barinthus Biotherapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPTN) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceUrgent Nvidia WarningAltimetryDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiNose, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
